Project Grant R43EY038160
- The National Eye Institute (NEI) awarded Kineolabs, Inc. a $300,001 Project Grant under the Vision Research program (CFDA 93.867) to develop a portable, low-cost line-scan swept-source optical coherence tomography (LS-SS-OCT) imaging system. The objective is to use this LS-SS-OCT technology for early detection and monitoring of age-related macular degeneration (AMD), diabetic retinopathy, and other eye diseases. The project aims to make OCT imaging more affordable and accessible to reduce the...
- The National Eye Institute (NEI) awarded a $256,296 Project Grant (CFDA 93.867 - Vision Research) to The General Hospital Corporation (Massachusetts General Hospital) to develop new "Auto-Sensing, Instantaneous Adaptive Ranging Optical Coherence Tomography (OCTA)" technology. This technology aims to expand the imaging depth range of OCTA systems, enabling improved visualization of the critical peripheral retinal microvasculature. The project will leverage advances in integrated...
- This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) aims to develop and validate a novel Adaptive Optics Optical Coherence Tomography (AO-OCT) system tailored for high-resolution, wide-field retinal imaging in small animal models, specifically mice. The $305,000 project, awarded on September 1, 2025, with an expected completion date of August 31, 2026, has two key objectives: Develop and optimize a portable AO-OCT system with enhanced imaging capabilities...
- The National Eye Institute (NEI) awarded a $673,747 Project Grant to New York University (NYU) for the "Visible-to-Near-Infrared Spanning Optical Coherence Tomography for Retinal Imaging at the Half-Micron Scale" research project under the NEI's Vision Research program (CFDA 93.867). The grant aims to develop advanced optical coherence tomography (OCT) techniques to enable more accurate in vivo measurement and localization of macular pigments and retinal pigment epithelium melanosomes,...
- This is a Cooperative Agreement award from the National Eye Institute (NEI), part of the U.S. Department of Health and Human Services, under the Vision Research federal grant program (CFDA 93.867). The $791,994 award, which began on September 1, 2025, supports the development of a next-generation ophthalmic microscope with integrated optical coherence tomography (OCT) imaging capabilities. The project aims to overcome limitations of current ophthalmic surgery microscopes by enabling more...
- This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), is providing $306,462 to Ifocus Imaging LLC to develop a software platform called OCT-ART-DR. The platform will automate the diagnosis and staging of diabetic retinopathy using optical coherence tomography angiography (OCTA) imaging and artificial intelligence. The key products to be delivered under this award include: 1) Improved AI-based segmentation of OCTA image...
- This federal Project Grant award of $315,825.00 from the National Eye Institute (CFDA 93.867 Vision Research) supports the development of a new, non-invasive, remote photonic technology for intraocular pressure (IOP) biomonitoring in glaucoma patients. The technology, called Photonic IOP Biomonitoring (PIB), uses sound waves and laser speckle pattern monitoring to deduce IOP without the need for physical eye contact or clinician interpretation. The goal is to miniaturize PIB into monoculars or...
- The National Eye Institute (NEI), part of the Department of Health and Human Services, awarded a $113,274 Project Grant to the Texas A&M University System Health Science Center (TAMU HSC) under the Vision Research federal grant program (CFDA 93.867). The grant, awarded on June 1, 2025, aims to develop innovative surgical techniques using ultrafast, nonthermal lasers for treating vitreoretinal and posterior segment disorders of the eye. The project will evaluate the use of femtosecond...
- The National Eye Institute (NEI), part of the National Institutes of Health, awarded a $331,131 Project Grant under the Vision Research program (CFDA 93.867) to Physical Sciences Inc. (PSI) to develop and validate a high-resolution retinal imaging system with light flicker capabilities. This system aims to enable objective characterization of the photoreceptor response to light and quantify differences between normal and diseased eyes, particularly for patients with diabetic retinopathy. PSI,...
- This federal Project Grant award of $598,108 from the National Eye Institute (CFDA 93.867 Vision Research) supports the development of innovative ophthalmic imaging technologies and novel objective, quantifiable functional biomarkers for cone photoreceptors. The primary aims are to: 1) Develop next-generation optical coherence tomography (OCT) technologies to enable functional photoreceptor imaging over a wide retinal area and at high topographical resolution; and 2) Develop novel objective,...
The National Eye Institute (NEI) awarded a Project Grant of $305,853 to Bluebird Photonics, Inc. under the Vision Research federal grant program (CFDA 93.867) to develop a novel light source for robust multi-MHz retinal optical coherence tomography (OCT). The project aims to enable next-generation OCT technology that can provide diagnostic screening and visualization of both the central and peripheral retinal areas through a roughly 50-fold increase in imaging speed. This advancement is powered by a novel laser technology called stretched-pulse-mode-locking, recently developed by the founders of Bluebird Photonics. The Phase I STTR support will allow Bluebird to refine the laser design and advance it from a prototype to a turnkey, environmentally robust commercial laser. Key objectives include implementing a bias-free, Sagnac-loop amplitude modulator and developing a closed-loop locking mechanism to ensure stable synchronization between the modulator and optical cavity resonance. The resulting laser will offer significant improvements over existing OCT technology in speed, cost, stability, reliability, and ease of integration, serving as a catalyst for further development of ultrawide-field OCT instrumentation and supporting clinical evaluation across a range of eye diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/23/25 | ||
| Not listed | $305.9k | 9/18/25 |